FDA’s New China Director Looks To Strengthen CFDA Ties
This article was originally published in PharmAsia News
August saw a change in the US FDA’s point person for China, as long-term FDA China director Chris Hickey left for a positon with Pfizer and Leigh Verbois took the charge with a mission to further develop strong ties with the China FDA amid the Chinese regulator’s hectic efforts to jumpstart regulatory reforms.
You may also be interested in...
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.
China insurance giant snatches up stakes in Japanese pharma and a traditional Chinese medicines maker with a $465m spending spree.
With vaccines perhaps the ultimate weapon to fight the coronavirus, a developer in China sees a big chunk of investment with potentially more companies to see funding coming.